Jupiter Asset Management LTD Biocryst Pharmaceuticals Inc Transaction History
Jupiter Asset Management LTD
- $9.74 Billion
- Q1 2025
A detailed history of Jupiter Asset Management LTD transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 2,148,969 shares of BCRX stock, worth $18.4 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,148,969
Previous 1,177,929
82.44%
Holding current value
$18.4 Million
Previous $8.86 Million
81.95%
% of portfolio
0.17%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
294Shares Held
180MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$185 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$171 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$76.3 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$74.4 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$66.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.59B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...